Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02766946
Other study ID # SJSL12013
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 24, 2013
Est. completion date December 22, 2015

Study information

Verified date April 2024
Source Centre Hospitalier Saint Joseph Saint Luc de Lyon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Ventilatory support during critical phase result in inactivity of respiratory muscles especially diaphragm muscle. These inactivity also result in change of contractile capability and quick muscular atrophy. The aim of the study is to visualize the evolution of diaphragm thickness by echography during Mechanical Ventilation for patients with septic shock or acute respiratory distress syndrome and to compare with the evolution for patients under non-invasive ventilation and those with spontaneous ventilation. Measurements will be performed at day 1, day 5 and day 10 (if patient still under a mode of ventilation or in the unit). The evolution of diaphragm thickness will also be compared to pectoralis muscle atrophy, which is not involved in ventilation, in order to assess respective effect of ventilatory inactivity and undernutrition linked to intensive care.


Recruitment information / eligibility

Status Completed
Enrollment 97
Est. completion date December 22, 2015
Est. primary completion date December 17, 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age =18 years old - Group 1 : under Mechanical Ventilation (time of Mechanical Ventilation for at least 5 days) - Group 2 : under Non-invasive Ventilation - Group 3 : Spontaneous Ventilation - Non opposition of patient (Groups 2 and 3) or non-opposition of patient family member (Group 1) Exclusion Criteria: - Known diaphragmatic paralysis - Neurologic pathology with motor deficit - Pregnancy or breast-feeding woman

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ultrasound
An ultrasound of the right diaphragm will be performed on day 1, day 3, day 5 and day 10
Ultrasound
An ultrasound of the pectoral muscle will be performed on day 1, day 3, day 5 and day 10
Other:
Neuromyopathy score
A neuromyopathy score will be assessed on the extubation day
Respiratory performances
An assessment of the respiratory performances will be done on the extubation day, including higher expiratory pressure, higher inspiratory pressure, and occlusion pressure

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Saint Joseph Saint Luc de Lyon

Outcome

Type Measure Description Time frame Safety issue
Primary Change from day 1 diaphragm thickness at day 3 and day 5 Diaphragm thickness measured by ultrasound 1 day, 3 days and 5 days after introduction of Mechanical Ventilation
Secondary Diaphragm thickness measured by ultrasound 10 days after introduction of Mechanical Ventilation
Secondary Type of ventilatory support Define which type of ventilatory support is used (mechanical ventilation, non-invasive ventilation, or spontaneous ventilation) 10 days after start of ventilatory support
Secondary Ventilatory mode Ventilatory mode (controlled ventilation, pressure support ventilation) 10 days after start of ventilatory support
Secondary Pectoralis muscle thickness measured by ultrasound To compare the importance of this atrophy to those of diaphragmatic muscle 10 days after start of ventilatory support
Secondary Diaphragmatic strength Relation between diaphragmatic atrophy and decrease of diaphragmatic strength intraoperative
Secondary Early or late extubation failure rate (extubation performed before or after 48 hours) Relation between diaphragmatic atrophy importance and premature (<48h) or late extubation failure The last day of hospitalisation
Secondary MRC score (Medical Research Council) Relation between diaphragmatic atrophy and decrease of diaphragmatic strength intraoperative
Secondary Length of ventilation in hours 10 days after start of ventilatory support
Secondary Drug administration Presence of drug administration such as curare, corticoid or sedative. If yes : number of days with treatment 10 days after start of ventilatory support
Secondary Total positive end expiratory pressure 10 days after start of ventilatory support
Secondary External positive end expiratory pressure 10 days after start of ventilatory support
Secondary Respiratory rate 10 days after start of ventilatory support
Secondary Highest inspiratory pressure level 10 days after start of ventilatory support
Secondary Highest expiratory pressure level 10 days after start of ventilatory support
Secondary Volume of exhaled air 10 days after start of ventilatory support
See also
  Status Clinical Trial Phase
Recruiting NCT03649633 - Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock Phase 1/Phase 2
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Completed NCT05629780 - Temporal Changes of Lactate in CLASSIC Patients N/A
Recruiting NCT04796636 - High-dose Intravenous Vitamin C in Patients With Septic Shock Phase 1
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Recruiting NCT05066256 - LV Diastolic Function vs IVC Diameter Variation as Predictor of Fluid Responsiveness in Shock N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Recruiting NCT02899143 - Short-course Antimicrobial Therapy in Sepsis Phase 2
Recruiting NCT02565251 - Volemic Resuscitation in Sepsis and Septic Shock N/A
Recruiting NCT02676427 - Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler Examination
Recruiting NCT02580240 - Administration of Hydrocortisone for the Treatment of Septic Shock N/A
Completed NCT02638545 - Hemodynamic Effects of Dexmedetomidine in Septic Shock Phase 3
Terminated NCT02335723 - ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber N/A
Not yet recruiting NCT02547467 - TOADS Study: TO Assess Death From Septic Shock. N/A
Completed NCT02204852 - Co-administration of Iloprost and Eptifibatide in Septic Shock Patients Phase 2
Completed NCT02306928 - PK Analysis of Piperacillin in Septic Shock Patients N/A